8月 全球伙伴公司关闭了1.5亿美元的保健基金,超过其目标,投资于保健技术和AI驱动的保健技术。 August Global Partners closed its $150 million healthcare fund, exceeding its target, to invest in healthtech and AI-driven medtech.

8月 设在新加坡的保健和技术投资者“全球伙伴”关闭了AGP保健基金,关闭金额达1.5亿美元,超过目标,将管理的总资产增加到3.5亿美元。 August Global Partners, a Singapore-based healthcare and technology investor, closed its AGP Healthcare Fund at $150 million—exceeding its target—bringing total assets under management to $350 million. 该基金在来自亚洲、欧洲和北美的投资者的支持下,以保健技术、数字保健、精密医学和AI驱动的医药技术方面的高增长机会为目标,符合其“生活更美好、老龄化更好”战略。 The fund, backed by investors from Asia, Europe, and North America, targets high-growth opportunities in healthtech, digital health, precision medicine, and AI-driven medtech, aligned with its “Living Better, Aging Better” strategy. 已经投资了基因测试初创公司Gene Solutions和外科技术平台Ultragreen.ai, It has already deployed capital into companies like genetic testing startup Gene Solutions and surgical tech platform Ultragreen.ai, generating early distributions to investors. 这家公司由新加坡生物医学部门的老兵创立,它利用深厚的专门知识和业务支持,支持创新的创始人推进基因组学、肿瘤学和慢性病管理的下一代护理。 The firm, founded by veterans of Singapore’s biomedical sector, leverages deep expertise and operational support to back innovative founders advancing next-generation care in genomics, oncology, and chronic disease management.